RENHENG ENT (03628) announced its interim results for 2025, reporting revenue of HK$60.64 million, representing a decrease of 0.6% compared to the same period last year. Net profit reached HK$13.058 million, marking a significant increase of 72.8% year-on-year. Basic earnings per share stood at HK$0.0162.

During the reporting period, the gross profit margin was 45.5%, an increase of 11.4 percentage points from the previous period's 34.1%. In terms of product gross margins, the gross margin from tobacco flavoring and machinery construction contracts for flavoring and fragrance blending increased from 32.2% in the first half of 2024 to 45.8% in the first half of 2025.